150 related articles for article (PubMed ID: 9045899)
1. Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.
Takeha S; Fujiyama Y; Bamba T; Sorsa T; Nagura H; Ohtani H
Jpn J Cancer Res; 1997 Jan; 88(1):72-81. PubMed ID: 9045899
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.
Saito K; Takeha S; Shiba K; Matsuno S; Sorsa T; Nagura H; Ohtani H
Int J Cancer; 2000 Apr; 86(1):24-9. PubMed ID: 10728590
[TBL] [Abstract][Full Text] [Related]
3. Differing expression of MMPs-1 and -9 and urokinase receptor between diffuse- and intestinal-type gastric carcinoma.
Migita T; Sato E; Saito K; Mizoi T; Shiiba K; Matsuno S; Nagura H; Ohtani H
Int J Cancer; 1999 Feb; 84(1):74-9. PubMed ID: 9988236
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.
Park IK; Kim BJ; Goh YJ; Lyu MA; Park CG; Hwang ES; Kook YH
Int J Cancer; 1997 May; 71(5):867-73. PubMed ID: 9180158
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
[TBL] [Abstract][Full Text] [Related]
6. Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions.
Ohtani H
Pathol Int; 1998 Jan; 48(1):1-9. PubMed ID: 9589457
[TBL] [Abstract][Full Text] [Related]
7. Detection of matrix metalloproteinase activity in human pancreatic cancer.
Koshiba T; Hosotani R; Wada M; Fujimoto K; Lee JU; Doi R; Arii S; Imamura M
Surg Today; 1997; 27(4):302-4. PubMed ID: 9086544
[TBL] [Abstract][Full Text] [Related]
8. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
9. Matrilysin is associated with progression of colorectal tumor.
Ishikawa T; Ichikawa Y; Mitsuhashi M; Momiyama N; Chishima T; Tanaka K; Yamaoka H; Miyazakic K; Nagashima Y; Akitaya T; Shimada H
Cancer Lett; 1996 Oct; 107(1):5-10. PubMed ID: 8913260
[TBL] [Abstract][Full Text] [Related]
10. [Implication of VEGF and MMPs in hepatic metastasis of human colon cancer].
Arii S; Ishigami S; Mori A; Onodera H; Imamura M
Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):436-40. PubMed ID: 9742524
[TBL] [Abstract][Full Text] [Related]
11. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
Sier CF; Kubben FJ; Ganesh S; Heerding MM; Griffioen G; Hanemaaijer R; van Krieken JH; Lamers CB; Verspaget HW
Br J Cancer; 1996 Aug; 74(3):413-7. PubMed ID: 8695357
[TBL] [Abstract][Full Text] [Related]
12. [Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer].
Koumura H; Sugiyama Y; Kunieda K; Saji S
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():324-31. PubMed ID: 9263524
[TBL] [Abstract][Full Text] [Related]
13. [Significance of MMP-9 and TIMP-1 production during liver metastasis in colorectal cancer].
Ogata Y; Ookita A; Kakegawa T
Nihon Rinsho; 1995 Jul; 53(7):1811-5. PubMed ID: 7630024
[TBL] [Abstract][Full Text] [Related]
14. Vascular extracellular matrix remodeling in cerebral aneurysms.
Bruno G; Todor R; Lewis I; Chyatte D
J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
[TBL] [Abstract][Full Text] [Related]
15. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.
Milani S; Herbst H; Schuppan D; Grappone C; Pellegrini G; Pinzani M; Casini A; Calabró A; Ciancio G; Stefanini F
Am J Pathol; 1994 Mar; 144(3):528-37. PubMed ID: 8129038
[TBL] [Abstract][Full Text] [Related]
17. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
18. Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
Kim TS; Kim YB
J Korean Med Sci; 1999 Jun; 14(3):263-70. PubMed ID: 10402168
[TBL] [Abstract][Full Text] [Related]
19. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R
Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416
[TBL] [Abstract][Full Text] [Related]
20. Stromal expression of urokinase-type plasminogen activator receptor (uPAR) is associated with invasive growth in primary liver cancer.
Akahane T; Ishii M; Ohtani H; Nagura H; Toyota T
Liver; 1998 Dec; 18(6):414-9. PubMed ID: 9869396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
